Literature DB >> 1499724

Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain.

A Suzuki1, M Yoshida, H Yamamoto, E Ozawa.   

Abstract

Dystrophin, a protein product of the Duchenne muscular dystrophy gene, is thought to associate with the muscle membrane by way of a glycoprotein complex which was co-purified with dystrophin. Here, we firstly demonstrate direct biochemical evidence for association of the carboxy-terminal region of dystrophin with the glycoprotein complex. The binding site is found to lie further inward than previously expected and confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. Since this portion corresponds well to the region that, when missing, results in severe phenotypes, our finding may provide a molecular basis of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499724     DOI: 10.1016/0014-5793(92)81265-n

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  44 in total

1.  The dystrophin-associated glycoprotein complex: what parts can you do without?

Authors:  H L Sweeney; E R Barton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Dystrobrevin and dystrophin: an interaction through coiled-coil motifs.

Authors:  H M Sadoulet-Puccio; M Rajala; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

Review 3.  The membrane-cytoskeleton interface: the role of dystrophin and utrophin.

Authors:  S J Winder
Journal:  J Muscle Res Cell Motil       Date:  1997-12       Impact factor: 2.698

Review 4.  Creatine kinase, cell membrane and Duchenne muscular dystrophy.

Authors:  E Ozawa; Y Hagiwara; M Yoshida
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

5.  Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle.

Authors:  Laurin M Hanft; Inna N Rybakova; Jitandrakumar R Patel; Jill A Rafael-Fortney; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-24       Impact factor: 11.205

6.  Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23-24.

Authors:  A H Ahn; M Yoshida; M S Anderson; C A Feener; S Selig; Y Hagiwara; E Ozawa; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.

Authors:  K Matsumura; I Nonaka; F M Tomé; K Arahata; H Collin; F Leturcq; D Récan; J C Kaplan; M Fardeau; K P Campbell
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

8.  Dystrophin and dystrophin-related protein in the central nervous system of normal controls and Duchenne muscular dystrophy.

Authors:  M Uchino; H Teramoto; H Naoe; T Miike; K Yoshioka; M Ando
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 9.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

10.  Dystrophin is a microtubule-associated protein.

Authors:  Kurt W Prins; Jill L Humston; Amisha Mehta; Victoria Tate; Evelyn Ralston; James M Ervasti
Journal:  J Cell Biol       Date:  2009-08-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.